QSS
GOSS icon

Quantitative Systematic Strategies’s Gossamer Bio GOSS Stock Holding History

Quantitative Systematic Strategies’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-477
Closed -$474K – 671
2020
Q3 		$474K Buy
477
+20
+4% +$21.2K 0.08% 335
2020
Q2 		$476K Buy
+457
New +$460K 0.09% 323
2020
Q1 		– Sell
-137
Closed -$172K – 368
2019
Q4 		$172K Buy
+137
New +$221K 0.03% 507

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Quantitative Systematic Strategies's GOSS Position: Q4 2020 in Review

Quantitative Systematic Strategies sold out of Gossamer Bio (GOSS) in Q4 2020, closing a stake of 477 shares — an estimated $474K sold.

Quantitative Systematic Strategies first reported a position in GOSS in Q4 2019 and held it in 3 quarters. The position peaked at $476K in Q2 2020. 122 funds tracked by Wall St. Rank hold GOSS as of Q4 2020.

  • Quantitative Systematic Strategies reported no remaining Gossamer Bio position as of Q4 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 477 Gossamer Bio shares in Q4 2020, an estimated $474K.
  • Quantitative Systematic Strategies first reported a position in Gossamer Bio in Q4 2019 and held it in 3 quarters.
  • Quantitative Systematic Strategies's Gossamer Bio position peaked at $476K in Q2 2020.
  • 122 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2020, filed 9 Feb 2021.